Full Title
Researching the Implementation of Acupuncture for Aromatase Inhibitor-related Arthralgias in Diverse Underserved Breast Cancer Survivors (ReIMAGINE)Purpose
Aromatase inhibitors are hormonal drugs used to lower the chance that breast cancer will come back. They are taken for several years by people with breast cancer that is fueled by estrogen, progesterone, or both hormones. A common side of effect of these drugs is joint pain. This pain may cause people to stop aromatase inhibitors early and lead to worse treatment outcomes.
Research has shown that acupuncture can help with joint pain related to aromatase inhibitors. However, these prior acupuncture studies did not include many people from certain backgrounds. Researchers are doing this study to see if acupuncture could also work well for people who were not well-represented in previous research.
If you join this study, you will be randomly assigned to get acupuncture over 10 weeks or your usual care. You will fill out questionnaires about your symptoms, quality of life, and use of pain treatments. If you are in the usual care group, you can receive 10 vouchers for acupuncture after the study is over.
Who Can Join
To join this study, there are a few conditions. You must:
- Have completed treatment for breast cancer at least 4 weeks before starting the study.
- Be taking aromatase inhibitors for 4 weeks or more and be planning to continue for at least another 14 weeks.
- Be experiencing moderate to severe joint pain from the aromatase inhibitor for 1 month or more.
- Not have previously received acupuncture for pain in the past year.
Researchers may also ask other questions to see if you are able to join this study.
Contact
For more information, please call Dr. Kevin Liou’s office at 646-608-8558.
Protocol
24-305
Disease Status
Relapsed or Refractory
Investigator
Co-Investigators
Diseases
ClinicalTrials.gov ID
NCT06814977